EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

A Phase 1 Study to Evaluate the Pharmacokinetic Drug‐Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy

Randolph P Matthews, Wendy Ankrom, Whitney Handy, Munjal Patel, Catherine Matthews, Zhiqing Xu, Kezia Gravesande, Shawn Searle, Howard Schwartz, S Aubrey Stoch, Marian Iwamoto

Clinical Pharmacology in Drug Development · 2025

DOI: 10.1002/cpdd.1492 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Clinical Pharmacology in Drug Development, 2025. Verfasst von Randolph P Matthews und 10 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, NJ, USA. Hauptthemen laut MEDLINE: Anti-HIV Agents, Drug Interactions, Methadone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Islatravir is a nucleoside reverse transcriptase translocation inhibitor in development for the treatment of HIV‐1. People living with HIV‐1 receiving methadone maintenance therapy may benefit from islatravir. This study was designed to evaluate single‐dose islatravir on steady‐state methadone pharmacokinetics. A nonrandomized, open‐label study (NCT04568603) was conducted and included adult participants receiving methadone therapy. Participants received their standard methadone therapy and a single oral dose of islatravir 60 mg concomitantly. Blood samples were collected to determine methadone and islatravir pharmacokinetics. Fourteen participants aged 26‐63 years were enrolled; 13 completed the study. The geometric mean ratios for methadone area under the concentration‐time curve from time 0 to 24 hours (AUC 0‐24 ), maximum plasma concentration (C max ), and concentration at 24 hours (C 24 ) were 1.03, 1.01, and 1.07, respectively. Similar effects were seen for the R‐ and S‐enantiomer of methadone (R‐methadone: AUC 0‐24 , 1.03; C max , 1.02; and C 24 , 1.06; S‐methadone: AUC 0‐24 , 1.03; C max , 1.01; and C 24 , 1.08). For islatravir, based on a comparison with historical data, the geometric mean ratios for AUC 0‐inf and C max were 1.18 and 0.86, respectively. Coadministration of a single dose of islatravir and methadone was generally well tolerated. Single‐dose islatravir did not affect steady‐state methadone pharmacokinetics in a clinically meaningful way.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsDrug InteractionsMethadoneAdultFemaleHumansMaleMiddle AgedArea Under CurveHIV InfectionsOpiate Substitution TreatmentReverse Transcriptase InhibitorsDeoxyadenosines

Stichwörter der Autor:innen

clinical pharmacologycoadministrationhuman immunodeficiency virusnucleoside reverse transcriptase translocation inhibitorpeople who inject drugs

Substanzen

Anti-HIV AgentsMethadoneReverse Transcriptase InhibitorsislatravirDeoxyadenosines

Autor:innen und Institutionen

  • Merck & Co., Inc., Rahway, NJ, USA.
  • ICON/PRA Health Sciences, Salt Lake City, UT, USA.
  • CenExel RCA, Hollywood, FL, USA.

Zitieren

APA

Matthews, R. P., Ankrom, W., Handy, W., Patel, M., Matthews, C., Xu, Z., Gravesande, K., Searle, S., Schwartz, H., Stoch, S. A., & Iwamoto, M. (2025). A Phase 1 Study to Evaluate the Pharmacokinetic Drug‐Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1492

Vancouver

Matthews RP, Ankrom W, Handy W, Patel M, Matthews C, Xu Z, et al. A Phase 1 Study to Evaluate the Pharmacokinetic Drug‐Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy. Clinical Pharmacology in Drug Development. 2025. doi:10.1002/cpdd.1492

BibTeX
@article{Matthews2025,
  author = {Matthews, Randolph P and Ankrom, Wendy and Handy, Whitney and Patel, Munjal and Matthews, Catherine and Xu, Zhiqing and Gravesande, Kezia and Searle, Shawn and Schwartz, Howard and Stoch, S Aubrey and Iwamoto, Marian},
  title = {A Phase 1 Study to Evaluate the Pharmacokinetic Drug‐Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2025},
  doi = {10.1002/cpdd.1492}
}
Kostenlos starten →